|
Market Closed -
Euronext Paris
16:55:00 18/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.8040 EUR | -0.74% |
|
-4.06% | +34.90% |
| 10-30 | Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 10-26 | Biosynex US Unit Bags $6 Million Award for DPP Biothreat Panel Assay Development | MT |
Company Valuation: Biosynex
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 151.6 | 289.9 | 141 | 85.85 | 18.51 | 11.17 |
| Change | - | 91.16% | -51.35% | -39.13% | -78.44% | -39.63% |
| Enterprise Value (EV) 1 | 130.6 | 193.2 | 105.9 | 125.7 | 71.44 | 64.36 |
| Change | - | 47.93% | -45.16% | 18.6% | -43.14% | -9.91% |
| P/E | 5.44x | 2.63x | 9.08x | -2.42x | -0.43x | -0.19x |
| PBR | 2.29x | 1.62x | 0.87x | 0.72x | 0.23x | 0.3x |
| PEG | - | 0x | -0.1x | 0x | -0x | 0x |
| Capitalization / Revenue | 0.99x | 0.76x | 0.72x | 0.92x | 0.18x | 0.12x |
| EV / Revenue | 0.85x | 0.5x | 0.54x | 1.35x | 0.71x | 0.68x |
| EV / EBITDA | 2.84x | 1.36x | 2.28x | -4.21x | -3.22x | -4.72x |
| EV / EBIT | 2.86x | 1.37x | 2.72x | -3.48x | -2.59x | -2.47x |
| EV / FCF | 7.61x | 2.62x | -3.59x | -2.83x | -43.6x | 4.54x |
| FCF Yield | 13.1% | 38.1% | -27.9% | -35.3% | -2.29% | 22% |
| Dividend per Share 2 | 0.2 | 2 | - | - | - | - |
| Rate of return | 1.2% | 7.6% | - | - | - | - |
| EPS 2 | 3.05 | 10.01 | 1.52 | -3.45 | -4.03 | -3.159 |
| Distribution rate | 6.56% | 20% | - | - | - | - |
| Net sales 1 | 153.9 | 382.5 | 196.6 | 92.98 | 101.2 | 95.19 |
| EBITDA 1 | 46.02 | 141.8 | 46.49 | -29.82 | -22.16 | -13.64 |
| EBIT 1 | 45.73 | 140.7 | 38.88 | -36.15 | -27.53 | -26.05 |
| Net income 1 | 31.37 | 104 | 15.66 | -36.95 | -43.33 | -58.22 |
| Net Debt 1 | -21.07 | -96.72 | -35.09 | 39.8 | 52.94 | 53.19 |
| Reference price 2 | 16.6000 | 26.3200 | 13.8000 | 8.3500 | 1.7200 | 0.5960 |
| Nbr of stocks (in thousands) | 9,135 | 11,014 | 10,220 | 10,281 | 10,761 | 18,748 |
| Announcement Date | 21/04/21 | 25/04/22 | 28/04/23 | 30/04/24 | 30/04/25 | 07/05/26 |
1EUR in Million2EUR
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 16.45M | ||
| 34.64x | 4.1x | 15.4x | 2.48% | 181B | ||
| 22.15x | 3.76x | 13.44x | 2.77% | 125B | ||
| 27.38x | 4.87x | 16.69x | 1.13% | 121B | ||
| 31.38x | 3.03x | 12.19x | 2.27% | 90.52B | ||
| 18.59x | 0.22x | 13.83x | 0.68% | 66.9B | ||
| 43.91x | 3.87x | 13.16x | 1.94% | 58.68B | ||
| 45.82x | 11.51x | 32.28x | -.--% | 54.38B | ||
| 27.89x | 6.9x | 17.49x | 1.44% | 48.46B | ||
| 46.12x | 3.46x | 12.8x | 0.5% | 35.4B | ||
| Average | 33.10x | 4.63x | 16.37x | 1.47% | 78B | |
| Weighted average by Cap. | 31.34x | 4.35x | 15.80x | 1.77% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ALBIO Stock
- Valuation Biosynex
Select your edition
All financial news and data tailored to specific country editions
















